Cita APA

Beelen, K., Opdam, M., Severson, T. M., Koornstra, R. H. T., Vincent, A. D., Hauptmann, M., . . . Linn, S. C. (2013). CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment. Springer US.

Chicago Style Citation

Beelen, K., et al. CYP2C19*2 Predicts Substantial Tamoxifen Benefit in Postmenopausal Breast Cancer Patients Randomized between Adjuvant Tamoxifen and No Systemic Treatment. Springer US, 2013.

Cita MLA

Beelen, K., et al. CYP2C19*2 Predicts Substantial Tamoxifen Benefit in Postmenopausal Breast Cancer Patients Randomized between Adjuvant Tamoxifen and No Systemic Treatment. Springer US, 2013.